KR100999261B1 - 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법 - Google Patents
여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법 Download PDFInfo
- Publication number
- KR100999261B1 KR100999261B1 KR20070101391A KR20070101391A KR100999261B1 KR 100999261 B1 KR100999261 B1 KR 100999261B1 KR 20070101391 A KR20070101391 A KR 20070101391A KR 20070101391 A KR20070101391 A KR 20070101391A KR 100999261 B1 KR100999261 B1 KR 100999261B1
- Authority
- KR
- South Korea
- Prior art keywords
- dna
- expression
- seq
- female
- genes
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
GBAcc | 유전자 이름 | 공식유전자심볼 |
BM759549 | Aldolase C, fructose-bisphosphate | ALDOC |
BM788742 | Armadillo repeat containing 6 | ARMC6 |
BM766969 | Actin related protein 2/3 complex, subunit 4, 20kDa | ARPC4 |
BM795885 | BCL2/adenovirus E1B 19kDa interacting protein 1 | BNIP1 |
BM792946 | Chromosome 1 open reading frame 122 | C1orf122 |
BM754866 | Chromosome 20 open reading frame 19 | C20orf19 |
BM762306 | Chromosome 3 open reading frame 1 | C3orf1 |
BM740544 | Chromosome 9 open reading frame 88 | C9orf88 |
AI796642, BM743084 | CAP, adenylate cyclase-associated protein 1 (yeast) | CAP1 |
BM790712 | Cyclin D2 | CCND2 |
BM754343 | Chaperonin containing TCP1, subunit 5 (epsilon) | CCT5 |
BM750659 | CD47 molecule | CD47 |
AB014522 | Cytoplasmic linker associated protein 1 | CLASP1 |
BM750709 | Chloride intracellular channel 5 | CLIC5 |
BM748783 | CSE1 chromosome segregation 1-like (yeast) | CSE1L |
BM786046 | Catenin (cadherin-associated protein), beta 1, 88kDa | CTNNB1 |
BM794137 | Chromosome X open reading frame 26 | CXorf26 |
BM782578 | Cysteine-rich, angiogenic inducer, 61 | CYR61 |
BM791387 | DEP domain containing 6 | DEPDC6 |
BM979081 | Der1-like domain family, member 3 | DERL3 |
BM782883 | DiGeorge syndrome critical region gene 6-like | DGCR6L |
BM749552 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | DHX9 |
BM759512, BM770073 | Desmoplakin | DSP |
BM737612 | Echinoderm microtubule associated protein like 3 | EML3 |
BM785896 | Family with sequence similarity 8, member A1 | FAM8A1 |
BM781868 | Farnesyl-diphosphate farnesyltransferase 1 | FDFT1 |
BM791018 | Farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase) | FDPS |
BM738725 | GIPC PDZ domain containing family, member 1 | GIPC1 |
BM792998 | Heterogeneous nuclear ribonucleoprotein A3 | HNRPA3 |
BM745313 | Heterogeneous nuclear ribonucleoprotein M | HNRPM |
BM739441 | HtrA serine peptidase 1 | HTRA1 |
BM772782 | IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast) | IMP3 |
BM794327 | Insulin induced gene 1 | INSIG1 |
BM786790 | Iroquois homeobox protein 2 | IRX2 |
BM792931 | Integrin beta 1 binding protein 1 | ITGB1BP1 |
BM754695 | Kinesin family member 15 | KIF15 |
BM770718 | Lactate dehydrogenase A | LDHA |
BM743834 | LEM domain containing 2 | LEMD2 |
BM773111 | Lamin B2 | LMNB2 |
BM759079 | Similar to hypothetical protein MGC27019 | LOC389833 |
CB104921 | Similar to bK246H3.1 (immunoglobulin lambda-like polypeptide 1, pre-B-cell specific) | LOC91316 |
BM767087 | Lymphocyte antigen 6 complex, locus D | LY6D |
BM788702 | Macrophage erythroblast attacher | MAEA |
BM753075 | Midnolin | MIDN |
BM751644 | Microphthalmia-associated transcription factor | MITF |
BM049852, BM792810 | Mevalonate kinase (mevalonic aciduria) | MVK |
BM768333 | Myeloma overexpressed 2 | MYEOV2 |
BM767045 | Nuclear receptor coactivator 4 | NCOA4 |
BM783408 | Neuroepithelial cell transforming gene 1 | NET1 |
BM795368 | Nuclear distribution gene C homolog (A. nidulans) | NUDC |
BM792605 | Platelet-activating factor acetylhydrolase, isoform Ib, alpha subunit 45kDa | PAFAH1B1 |
BM782132 | Proliferating cell nuclear antigen | PCNA |
BM748943 | Pelota homolog (Drosophila) | PELO |
BM792234 | Pescadillo homolog 1, containing BRCT domain (zebrafish) | PES1 |
BM763958 | Phosphatidylinositol glycan, class C | PIGC |
BM763943 | Phosphatidylinositol transfer protein, alpha | PITPNA |
BM785430 | Paired-like homeodomain transcription factor 1 | PITX1 |
BM751239 | Pyruvate kinase, muscle | PKM2 |
BM760618 | Polymerase (RNA) II (DNA directed) polypeptide F | POLR2F |
BM770840 | Protein phosphatase 1, regulatory (inhibitor) subunit 13 like | PPP1R13L |
BM790065 | Protein phosphatase 4, regulatory subunit 2 | PPP4R2 |
BM786452 | Palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) | PPT1 |
BM791369 | Peroxiredoxin 1 | PRDX1 |
BC034545 | PRP8 pre-mRNA processing factor 8 homolog (yeast) | PRPF8 |
BM751738, BM787248 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 | PSMD1 |
BM791065 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 | PSMD11 |
BM793399 | R3H domain and coiled-coil containing 1 | R3HCC1 |
BM744761 | Arginyl-tRNA synthetase | RARS |
BM741368 | Ras association (RalGDS/AF-6) domain family 7 | RASSF7 |
BC005290 | RNA (guanine-7-) methyltransferase | RNMT |
BM741551 | Ribosomal protein L26 | RPL26 |
BM787845 | Ribonucleotide reductase M1 polypeptide | RRM1 |
BE928214 | R-spondin homolog (Xenopus laevis) | RSPO1 |
BM786739 | RUN and TBC1 domain containing 1 | RUTBC1 |
BM737849 | S100 calcium binding protein A2 | S100A2 |
BM790077 | Secretory carrier membrane protein 3 | SCAMP3 |
BM788902 | Stratifin | SFN |
BM767159 | Splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) | SFPQ |
BM762738 | Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) | SFRS1 |
BM739117, BM789779, BM792207 | Splicing factor, arginine/serine-rich 2 | SFRS2 |
BM755276 | Stress-induced-phosphoprotein 1 (Hsp70/Hsp90-organizing protein) | STIP1 |
BM755576 | TAR DNA binding protein | TARDBP |
BQ082251 | TBC1 domain family, member 4 | TBC1D4 |
BM789455 | Transferrin receptor (p90, CD71) | TFRC |
BM756004 | Triosephosphate isomerase 1 | TPI1 |
BM744635 | Tubulin, beta | TUBB |
BM773030 | Tubulin, beta 3 | TUBB3 |
BM771505 | Von Hippel-Lindau tumor suppressor | VHL |
BM792805 | WD repeat domain 74 | WDR74 |
BM749405 | Zinc fingers and homeoboxes 1 | ZHX1 |
BM770317 | Zinc finger protein 302 | ZNF302 |
GenBank | 유전자 이름 | 공식 유전자 심볼 |
BM740608 | Actin, beta | ACTB |
BM768621 | ADAM metallopeptidase domain 8 | ADAM8 |
BM749602 | Ankyrin repeat and IBR domain containing 1 | ANKIB1 |
BM765479, BM782554 | Rho/rac guanine nucleotide exchange factor (GEF) 2 | ARHGEF2 |
BM794293 | ADP-ribosylation factor-like 16 | ARL16 |
BM762356 | Cyclic AMP phosphoprotein, 19 kD | ARPP-19 |
BM741157 | BCL2-like 1 | BCL2L1 |
BM793770 | Chromosome 17 open reading frame 40 | C17orf40 |
BM751046 | Calcium binding and coiled-coil domain 1 | CALCOCO1 |
BM757056 | Cyclin B1 interacting protein 1 | CCNB1IP1 |
BM749946 | CUB domain containing protein 1 | CDCP1 |
BM753145 | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) | CDKN1A |
BM755133 | Carboxylesterase 2 (intestine, liver) | CES2 |
BM786965 | Chromodomain helicase DNA binding protein 2 | CHD2 |
BM752296 | Coatomer protein complex, subunit alpha | COPA |
BM787147 | Death associated protein 3 | DAP3 |
BM745250 | Dickkopf homolog 1 (Xenopus laevis) | DKK1 |
BM792504 | DnaJ (Hsp40) homolog, subfamily B, member 11 | DNAJB11 |
BM755356 | Dynein, cytoplasmic 1, heavy chain 1 | DYNC1H1 |
BM790644 | Eukaryotic translation initiation factor 1 | EIF1 |
BM784466 | Eukaryotic translation initiation factor 4A, isoform 2 | EIF4A2 |
BM787313 | Eukaryotic translation initiation factor 5 | EIF5 |
BM790578 | Elongation factor, RNA polymerase II, 2 | ELL2 |
BM750932, BM754350 | Glutamyl-prolyl-tRNA synthetase | EPRS |
AU280079 | Coagulation factor III (thromboplastin, tissue factor) | F3 |
BM739071 | Family with sequence similarity 102, member B | FAM102B |
BM788839 | Family with sequence similarity 89, member B | FAM89B |
BM792813 | Hypothetical protein FLJ22795 | FLJ22795 |
BM759296 | CXYorf1-related protein | FLJ25222 |
BM761603 | FOS-like antigen 1 | FOSL1 |
BM751078 | Follistatin-like 3 (secreted glycoprotein) | FSTL3 |
BM751152 | Fragile X mental retardation, autosomal homolog 2 | FXR2 |
BM751418 | Golgi autoantigen, golgin subfamily a, 4 | GOLGA4 |
BM745177 | G protein-coupled receptor 56 | GPR56 |
BM788582 | Hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | HIF1A |
BM746717 | Heterogeneous nuclear ribonucleoprotein D-like | HNRPDL |
BM763048 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | HS3ST1 |
BM762289 | Interphase cyctoplasmic foci protein 45 | ICF45 |
BM773187 | Integrin, beta 4 | ITGB4 |
BM751795 | Kruppel-like factor 5 (intestinal) | KLF5 |
BM751030 | Kruppel-like factor 6 | KLF6 |
BM741864 | Microtubule-associated protein 1 light chain 3 beta | MAP1LC3B |
BM788834 | Mitogen-activated protein kinase kinase 3 | MAP2K3 |
BM784775 | MAP kinase interacting serine/threonine kinase 2 | MKNK2 |
BM741311 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | MLL |
BM761778 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | MLLT4 |
BM784915 | Mercaptopyruvate sulfurtransferase | MPST |
BM756630 | Nuclear receptor coactivator 3 | NCOA3 |
BM786674 | NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa | NDUFV3 |
BM749562, BM753935, BM787950 | Nuclear factor (erythroid-derived 2)-like 2 | NFE2L2 |
BM745221 | Notch homolog 1, translocation-associated (Drosophila) | NOTCH1 |
BM786385 | Niemann-Pick disease, type C1 | NPC1 |
AK000933 | Opsin 3 (encephalopsin, panopsin) | OPN3 |
BM771495 | Origin recognition complex, subunit 4-like (yeast) | ORC4L |
BM790345 | Poly(A) binding protein, cytoplasmic 1 | PABPC1 |
BM769219 | Phosphatidylinositol glycan, class H | PIGH |
BM761640, BM781963 | Plasminogen activator, urokinase | PLAU |
BM773147 | Protein kinase D2 | PRKD2 |
BM794592 | Protease, serine, 8 (prostasin) | PRSS8 |
BM762848 | Phosphoserine aminotransferase 1 | PSAT1 |
BM761644 | PTK6 protein tyrosine kinase 6 | PTK6 |
BM787956 | Protein tyrosine phosphatase type IVA, member 1 | PTP4A1 |
BM745237 | Protein tyrosine phosphatase, non-receptor type 12 | PTPN12 |
BM744521 | Phosphorylase, glycogen; brain | PYGB |
BM787758 | Reticulon 3 | RTN3 |
BM742646 | RuvB-like 1 (E. coli) | RUVBL1 |
BM744942 | Seryl-tRNA synthetase | SARS |
BM759590 | SEC24 related gene family, member D (S. cerevisiae) | SEC24D |
BM790371 | Solute carrier family 2 (facilitated glucose transporter), member 1 | SLC2A1 |
BM787478 | Solute carrier family 38, member 2 | SLC38A2 |
BM756519 | Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | SLC3A2 |
BM786054 | Thrombospondin 1 | THBS1 |
BM773292 | Tribbles homolog 3 (Drosophila) | TRIB3 |
BM753459 | Tyrosyl-tRNA synthetase | YARS |
BM741902 | Zinc finger protein 36, C3H type, homolog (mouse) | ZFP36 |
CB104867 | Zinc finger protein 337 | ZNF337 |
TRE | TFs |
TFs의
Accession ID |
프로모터에서 관찰되는 빈도(%) | |
증가유전자군 | 감소유전자군 | |||
V$SREBP1_Q6 | SREBF1(SREBP1) | AB209609 | 66 | 0 |
V$LMO2COM_01 | LMO2 | NM_005574 | 52 | 0 |
V$AP2_Q6_01 | TFAP2A | NM_001032280 | 62 | 0 |
F$XBP1_Q2 | XBP1 | AK093842 | 60 | 0 |
V$MEF2_Q6 | MEF2A | AL831995 | 74 | 0 |
V$LEF1_Q2 | LEF1 | AK128255 | 64 | 0 |
V$OSF2_Q6 | RUNX2 (OSF2) | NM_004348 | 40 | 0 |
V$MAZR_01 | PATZ1 (MAZR) | NM_014323 | 40 | 0 |
V$AREB6_03 | ZEB1 (AREB6) | BX647794 | 18 | 0 |
V$HNF4_Q6 | HNF4A | NM_000457 | 72 | 52 |
V$AP2REP_01 | KLF12(AP2REP) | NM_007249 | 66 | 64 |
V$TTF1_Q6 | NKX2-1 (TTF1) | NM_003317 | 76 | 78 |
V$MYOD_Q6 | MYOD1 | NM_002478 | 74 | 78 |
V$AML1_01 | RUNX1(AML1) | NM_001001890 | 66 | 60 |
V$LYF1_01 | IKZF1(LYF1, ZNFN1A1) | AF432219 | 0 | 24 |
V$T3R_Q6 | THRA | AB209346 | 0 | 68 |
V$PITX2_Q2 | PITX2 | AK127829 | 0 | 24 |
V$NKX25_01 | NKX2-5 | BC025711 | 0 | 46 |
V$SOX5_01 | SOX5 | NM_152989 | 0 | 66 |
V$MYOGENIN_Q6 | MYOG | NM_002479 | 0 | 64 |
V$MEIS1_01 | MEIS1 | CR749827 | 0 | 64 |
V$IRF1_Q6 | IRF1 | AB209624 | 0 | 66 |
V$GATA3_01 | GATA3 | NM_001002295 | 0 | 78 |
V$TBX5_02 | TBX5 | NM_000192 | 0 | 48 |
V$AP1FJ_Q2 | AP1(FOS/JUN) | BX647104/ NM_002228 |
0 | 46 |
V$AREB6_02 | ZEB1 (AREB6) | BX647794 | 0 | 66 |
V$TBP_01 | TBP | BC110341 | 0 | 52 |
V$SP1_Q2_01 | SP1 | BQ774060 | 0 | 84 |
유전자 기호 | 프라이머 종류 | 프라이머 서열 |
ARPP-19 | 센스(서열번호1) | AAAGCCTGGAGGTTCAGATTTC |
안티센스(서열번호2) | GCAGTAGGAAGTTGCTTGTTCT | |
INSIG1 | 센스(서열번호3) | CCTGGCATCATCGCCTGTT |
안티센스(서열번호4) | AGAGTGACATTCCTCTGGATCTG | |
SFN | 센스(서열번호5) | AGGCCGAACGCTATGAGGA |
안티센스(서열번호6) | CCTCGTTGCTTTTCTGCTCAA | |
STIP1 | 센스(서열번호7) | CAAGGGCTATTCACGAAAAGCA |
안티센스(서열번호8) | TTTCAGTTGAGGGTTATTTGCCT | |
FDFT1 | 센스(서열번호9) | ATGGAGTTCGTGAAATGCCTT |
안티센스(서열번호10) | TGCGACTGGTCTGATTGAGATA | |
CDKN1A | 센스(서열번호11) | GTCACTGTCTTGTACCCTTGTG |
안티센스(서열번호12) | CGGCGTTTGGAGTGGTAGAAA | |
CTNNB1 | 센스(서열번호13) | GCTACTCAAGCTGATTTGATGGA |
안티센스(서열번호14) | GGTAGTGGCACCAGAATGGATT | |
TRIB3 | 센스(서열번호15) | AAGCGGTTGGAGTTGGATGAC |
안티센스(서열번호16) | CACGATCTGGAGCAGTAGGT | |
CYR61 | 센스(서열번호17) | ACCGCTCTGAAGGGGATCT |
안티센스(서열번호18) | ACTGATGTTTACAGTTGGGCTG | |
HNRPMa | 센스(서열번호19) | CTCTTAATGGACGCTGAAGGAAA |
안티센스(서열번호20) | GTAGCCATCACCTTTTGCATTG | |
HNRPMb | 센스(서열번호21) | GCGGCGACGGAGATCAAAA |
안티센스(서열번호22) | CCTCTTCTCATTCTGAGCAGGT | |
ITGB1BP1 | 센스(서열번호23) | CGGATGGTGTGTTACGATGAC |
안티센스(서열번호24) | TGATAAACCCACAGGCTGTATTC | |
ARHGEF2 | 센스(서열번호25) | ATGTCTCGGATCGAATCCCTC |
안티센스(서열번호26) | ACATGGTCATGCCTGAAACTG | |
BCL2L1 | 센스(서열번호27) | CTGTGCGTGGAAAGCGTAGA |
안티센스(서열번호28) | TGCTGCATTGTTCCCATAGAG | |
KLF5 | 센스(서열번호29) | TCAGTCGTAGACCAGTTCTTCA |
안티센스(서열번호30) | GTAGAGGCCAGTTCTCAGGTG | |
ARPC4 | 센스(서열번호31) | AACGACACAACAAGCCGGAA |
안티센스(서열번호32) | TGGAGCCCTCAATCAGAACCT | |
PCNA | 센스(서열번호33) | GGCTCCATCCTCAAGAAGGTG |
안티센스(서열번호34) | GGGACGAGTCCATGCTCTG | |
NCOA4 | 센스(서열번호35) | CTGGCTCCTCAAGAGTGAAAAA |
안티센스(서열번호36) | GCCAATCTGATAGGTCCATCTCA | |
PRDX1 | 센스(서열번호37) | CGGAGATCATTGCTTTCAGTGA |
안티센스(서열번호38) | AGGTGTATTGACCCATGCTAGAT | |
PSMD11 | 센스(서열번호39) | GAAGAGGCAGTGCAAGTCAAA |
안티센스(서열번호40) | GGGTCGTACATACTTCAGGAGTC | |
CES2 | 센스(서열번호41) | GATGATGGCGGACTCCATGTT |
안티센스(서열번호42) | TGTAGTTGCCCCCAAAGAAAC | |
PLAU | 센스(서열번호43) | GCTTGTCCAAGAGTGCATGGT |
안티센스(서열번호44) | AGGGCTGGTTCTCGATGGT |
유전자 기호 | 프라이머 종류 | 프라이머 서열 |
PITX2 | 센스(서열번호45) | CACCATCCCCAGCCGTTAG |
안티센스(서열번호46) | CGCCCACGTCCTCATTCTT | |
TBX5 | 센스(서열번호47) | GACCATCCCTATAAGAAGCCCT |
안티센스(서열번호48) | TGTGCCGACTCTGTCCTGTA | |
XBP1 | 센스(서열번호49) | CCTACTGGATGCTTACAGTGACT |
안티센스(서열번호50) | AGTGTCCTCCCAAGAATGGTTTA | |
AP2C | 센스(서열번호51) | CTGTTGCTGCACGATCAGACA |
안티센스(서열번호52) | CAGGGACTGAGCAGAAGACCT | |
IKZF1 (LYF1,ZNFN1A1) | 센스(서열번호53) | GACGCACTCCGTCATTAAAGA |
안티센스(서열번호54) | CGACGTTACTTGCTAGTCTGTC | |
MYOG | 안티센스(서열번호55) | GCTGTATGAGACATCCCCCTA |
센스(서열번호56) | CGACTTCCTCTTACACACCTTAC |
유전자 | 올리고 서열 | 표적 서열 |
XBP1_#3 | CCGGGAACAGCAAGTGGTAGATTTACTCGAGTAAATCTACCACTTGCTGTTCTTTTT (서열번호 57) | GAACAGCAAGTGGTAGATTTA (서열번호 58) |
XBP1_#5 | CCGGAGATCGAAAGAAGGCTCGAATCTCGAGATTCGAGCCTTCTTTCGATCTTTTTT (서열번호 59) | AGATCGAAAGAAGGCTCGAAT (서열번호 60) |
TBX5_#2 | CCGGGCCGACGATCACAGATACAAACTCGAGTTTGTATCTGTGATCGTCGGCTTTTT (서열번호 61) | GCCGACGATCACAGATACAAA (서열번호 62) |
TBX5_#4 | CCGGGCTGCACAGAATGTCAAGAATCTCGAGATTCTTGACATTCTGTGCAGCTTTTT (서열번호 63) | GCTGCACAGAATGTCAAGAAT (서열번호 64) |
PITX2_#2 | CCGGCCCAGGCTATTCCTACAACAACTCGAGTTGTTGTAGGAATAGCCTGGGTTTTT (서열번호 65) | CCCAGGCTATTCCTACAACAA (서열번호 66) |
PITX2_#3 | CCGGCCAGTCTCAACAGCCTGAATACTCGAGTATTCAGGCTGTTGAGACTGGTTTTT (서열번호 67) | CCAGTCTCAACAGCCTGAATA (서열번호 68) |
ZNFN1A1_#3 | CCGGCCGTTGGTAAACCTCACAAATCTCGAGATTTGTGAGGTTTACCAACGGTTTTTG (서열번호 69) | CCGTTGGTAAACCTCACAAAT (서열번호 70) |
ZNFN1A1_#4 | CCGGGCCGAAGCTATAAACAGCGAACTCGAGTTCGCTGTTTATAGCTTCGGCTTTTTG (서열번호 71) | GCCGAAGCTATAAACAGCGAA (서열번호 72) |
TFAP2C_#3 | CCGGCCTATGTCTGTGAAGCCGAATCTCGAGATTCGGCTTCACAGACATAGGTTTTT (서열번호 73) | CCTATGTCTGTGAAGCCGAAT (서열번호 74) |
TFAP2C_#4 | CCGGGCCCAGCAACTGTGTAAAGAACTCGAGTTCTTTACACAGTTGCTGGGCTTTTT (서열번호 75) | GCCCAGCAACTGTGTAAAGAA (서열번호 76) |
MYOG_#4 | CCGGGTGTAAGGTGTGTAAGAGGAACTCGAGTTCCTCTTACACACCTTACACTTTTT (서열번호 77) | GTGTAAGGTGTGTAAGAGGAA (서열번호 78) |
MYOG_#5 | CCGGGCGCAGTGCCATCCAGTACATCTCGAGATGTACTGGATGGCACTGCGCTTTTT (서열번호 79) | GCGCAGTGCCATCCAGTACAT (서열번호 80) |
Claims (11)
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 여성 호르몬 결핍에 의한 여성 피부 노화 억제제 스크리닝 방법으로서,세포에 시험 화합물을 처리하는 단계; 및시험 화합물 처리 후 세포 내 R3HCC1 유전자의 발현이 촉진되는지 확인하는 단계를 포함하는 여성 호르몬 결핍에 의한 여성 피부 노화 억제제 스크리닝 방법.
- 제9항에 있어서,상기 세포 내 R3HCC1 유전자의 발현이 촉진되는지 확인하는 단계에 부가하여,시험 화합물 처리 후 세포 내 IINSIG1, RSPO1, IMP3, FDFT1, SFPQ, PCNA, SFRS2, DERL3, PRPF8, STIP1, MVK, LOC389833, DGCR6L, SFN, ARPC4, RARS, C3orf1, PELO, NUDC, NCOA4, PSMD11, SFRS1, CTNNB1, CCT5, CYR61, HNRPM, LDHA, PRDX1, RUTBC1, TFRC, TUBB3, IRX2, ZHX1, LOC91316, PAFAH1B1, TARDBP, ZNF302, CXorf26, KIF15, ITGB1BP1, FAM8A1, NET1, CCND2, BNIP1, ARMC6, ALDOC, CAP1, CD47, CLIC5, RASSF7, C9orf88, CSE1L, LEMD2, CLASP1, DEPDC6, FDPS, C1orf122, MYEOV2, EML3, LY6D, MAEA, MITF, MIDN, PITX1, HTRA1, PPP1R13L, PPP4R2, PKM2, GIPC1, RRM1, RPL26, WDR74, S100A2, SCAMP3, TBC1D4, TUBB, PSMD1, TPI1, DSP, HNRPA3, PES1, POLR2F, RNMT, PITPNA, VHL, DHX9, LMNB2, PPT1, C20orf19 및 PIGC 유전자로 이루어진 군에서 선택되는 하나 이상의 유전자의 발현이 촉진되는지 확인하는 단계를 포함하는 여성 호르몬 결핍에 의한 여성 피부 노화 억제제 스크리닝 방법.
- 제9항에 있어서,상기 세포 내 R3HCC1 유전자의 발현이 촉진되는지 확인하는 단계에 부가하여,시험 화합물 처리 후 세포 내 DKK1, ELL2, FOSL1, HNRPDL, PLAU, FAM89B, THBS1, ARHGEF2, PRKD2, TRIB3, CES2, F3, CDKN1A, EIF4A2, EIF5, HS3ST1, CALCOCO1, KLF5, KLF6, MLL, NPC1, ADAM8, BCL2L1, COPA, FLJ25222, DYNC1H1, FAM102B, MAP2K3, ARL16, ITGB4, MLLT4, NDUFV3, NFE2L2, FSTL3, PRSS8, PTK6, SLC2A1, SLC38A2, FLJ22795, ZFP36, ARPP-19, HIF1A, FXR2, CDCP1, CCNB1IP1, GOLGA4, ICF45, MPST, DNAJB11, EPRS, MKNK2, MAP1LC3B, NCOA3, ORC4L, PIGH, PSAT1, PABPC1, EIF1, RUVBL1, SARS, ZNF337, GPR56, C17orf40, OPN3, DAP3, PYGB, PTP4A1, PTPN12, RTN3, SEC24D, SLC3A2, YARS, ACTB, CHD2, NOTCH1 및 ANKIB1 유전자로 이루어진 군에서 선택되는 하나 이상의 유전자의 발현이 억제되는지 확인하는 단계를 포함하는 여성 호르몬 결핍에 의한 여성 피부 노화 억제제 스크리닝 방법.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20070101391A KR100999261B1 (ko) | 2007-10-09 | 2007-10-09 | 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법 |
PCT/KR2008/005945 WO2009048282A2 (en) | 2007-10-09 | 2008-10-09 | Method and kit for diagnosis of hormonal skin aging |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20070101391A KR100999261B1 (ko) | 2007-10-09 | 2007-10-09 | 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100027351A Division KR101317024B1 (ko) | 2010-03-26 | 2010-03-26 | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090036299A KR20090036299A (ko) | 2009-04-14 |
KR100999261B1 true KR100999261B1 (ko) | 2010-12-07 |
Family
ID=40549749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20070101391A KR100999261B1 (ko) | 2007-10-09 | 2007-10-09 | 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100999261B1 (ko) |
WO (1) | WO2009048282A2 (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102089444A (zh) | 2008-05-14 | 2011-06-08 | 德玛泰克国际公司 | 利用核酸分析方法来诊断黑素瘤和太阳能雀斑 |
JP2012501183A (ja) * | 2008-08-28 | 2012-01-19 | ダームテック インターナショナル | 皮膚サンプルの年齢範囲の決定方法 |
KR100964433B1 (ko) * | 2008-11-07 | 2010-06-16 | (주)아모레퍼시픽 | 피부 기능 향상 물질의 스크리닝 방법 |
AU2010279359A1 (en) * | 2009-08-07 | 2012-02-16 | The Wistar Institute | Compositions containing JARID1B inhibitors and methods for treating cancer |
MX368365B (es) | 2009-12-22 | 2019-09-30 | Avon Prod Inc | Composiciones estimuladoras de paxilina y usos cosmeticos de las mismas. |
US20110159125A1 (en) | 2009-12-29 | 2011-06-30 | Avon Products, Inc. | CGRP Compositions and Uses Thereof |
US20120034613A1 (en) * | 2010-08-03 | 2012-02-09 | Nse Products, Inc. | Apparatus and Method for Testing Relationships Between Gene Expression and Physical Appearance of Skin |
KR101886342B1 (ko) * | 2010-11-30 | 2018-08-10 | (주)아모레퍼시픽 | 피부 노화와 관련된 유전자 및 피부 노화를 방지하는 물질을 스크리닝하는 방법 |
PL2659004T3 (pl) * | 2010-12-30 | 2017-12-29 | Avon Products, Inc. | Modulacja dyneiny w skórze |
US20140303020A1 (en) * | 2011-08-02 | 2014-10-09 | The University Of Tokyo | Method for Assessing Myelodysplastic Syndrome or Myeloid Tumor Predisposition, Polypeptide and Antibody Therefor, and Candidate Screening Method for Therapeutic Drug or Prophylactic Drug Therefor |
US20140030716A1 (en) * | 2012-07-26 | 2014-01-30 | National Yang - Min University | Novel tumor marker, its monoclonal antibodies and usage |
US9168283B2 (en) | 2012-12-11 | 2015-10-27 | Avon Products, Inc. | Medemia nobilis extracts and methods of use |
WO2014092684A2 (en) | 2012-12-11 | 2014-06-19 | Avon Products, Inc. | Use of melicope extracts to improve conditions caused by excess lipids |
CN103805568B (zh) * | 2014-01-28 | 2015-10-28 | 北京师范大学 | 一种人icf45单克隆抗体的制备及应用 |
US20210109111A1 (en) * | 2016-11-25 | 2021-04-15 | Université Grenoble Alpes | New biomarkers of human skin aging |
EP3752645A4 (en) | 2018-02-14 | 2022-04-13 | Dermtech, Inc. | NEW GENE CLASSIFIERS AND THEIR USES IN NON-MELANOMA SKIN CANCERS |
WO2019236632A1 (en) * | 2018-06-04 | 2019-12-12 | Avon Products. Inc. | Protein biomarkers for identifying and treating aging skin and skin conditions |
CA3134936A1 (en) | 2019-03-26 | 2020-10-01 | Dermtech, Inc. | Novel gene classifiers and uses thereof in skin cancers |
CN110117615A (zh) * | 2019-05-20 | 2019-08-13 | 山东大学第二医院 | 一种psmd11基因条件性敲除小鼠模型的构建方法及其应用 |
WO2023060320A1 (en) * | 2021-10-15 | 2023-04-20 | Bod Science Limited | Topical protein based formulation |
-
2007
- 2007-10-09 KR KR20070101391A patent/KR100999261B1/ko active IP Right Grant
-
2008
- 2008-10-09 WO PCT/KR2008/005945 patent/WO2009048282A2/en active Application Filing
Non-Patent Citations (1)
Title |
---|
Experimental Dermatology Vol. 15, No. 2, pp83-94* |
Also Published As
Publication number | Publication date |
---|---|
WO2009048282A2 (en) | 2009-04-16 |
WO2009048282A3 (en) | 2009-09-17 |
KR20090036299A (ko) | 2009-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100999261B1 (ko) | 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법 | |
US20190062843A1 (en) | Micro-rna biomarkers and methods of using same | |
KR101618950B1 (ko) | 피부 자극 물질 스크리닝용 조성물 및 이를 이용한 피부 자극 물질의 스크리닝 방법 | |
EP3175244A1 (en) | Compositions for treatment of acute lymphoblastic leukemia and methods of use thereof | |
KR101283270B1 (ko) | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 | |
KR101360746B1 (ko) | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 | |
KR101360680B1 (ko) | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 | |
KR101360602B1 (ko) | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 | |
KR101360681B1 (ko) | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 | |
KR101360620B1 (ko) | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 | |
KR101317024B1 (ko) | 여성 호르몬 결핍으로 초래되는 여성 피부 노화 억제제 스크리닝 방법 | |
JP2013252136A (ja) | 肥満化リスク・糖尿病発症リスクの検出方法 | |
KR101844845B1 (ko) | 담도암 치료용 약물 감수성 예측용 조성물 | |
CN107034272B (zh) | Cxcl2在制备诊断或治疗肺腺癌工具中的应用 | |
CN107034270B (zh) | Clic3作为肺腺癌的诊治靶标 | |
WO2015037656A1 (ja) | オートファジーを調節するマイクロrna | |
EP2995956B1 (en) | Use of a diagnostic marker composition comprising apolipoprotein m for diagnosing alzheimer's disease | |
KR101543172B1 (ko) | 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 | |
EP3728639B1 (en) | Method of selection of an ire1-inhibitor therapy for patient suffering from cancer | |
JP2014128249A (ja) | 神経変性疾患の検査と治療に対するmiRNA又はその標的遺伝子の利用 | |
CN106119400B (zh) | C2cd4c在制备诊治下咽癌产品中的应用 | |
US20190264292A1 (en) | Use of h2a.z.1 as a hepatocellular carcinoma biomarker | |
KR101543173B1 (ko) | 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 | |
KR101543181B1 (ko) | 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 | |
KR20140130381A (ko) | 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131121 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20141120 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20151130 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161010 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170928 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181002 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190926 Year of fee payment: 10 |